tiprankstipranks
Trending News
More News >
Pharma Mar SA (PHMMF)
:PHMMF

Pharma Mar SA (PHMMF) Stock Statistics & Valuation Metrics

Compare
51 Followers

Total Valuation

Pharma Mar SA has a market cap or net worth of $1.88B. The enterprise value is $858.32M.
Market Cap$1.88B
Enterprise Value$858.32M

Share Statistics

Pharma Mar SA has 18,222,227 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,222,227
Owned by Insiders
Owned by Institutions

Financial Efficiency

Pharma Mar SA’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 5.09%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)5.09%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee349.71K
Profits Per Employee23.97K
Employee Count500
Asset Turnover0.50
Inventory Turnover0.16

Valuation Ratios

The current PE Ratio of Pharma Mar SA is 53.57. Pharma Mar SA’s PEG ratio is -0.50.
PE Ratio53.57
PS Ratio0.00
PB Ratio5.21
Price to Fair Value6.72
Price to FCF39.38
Price to Operating Cash Flow30.29
PEG Ratio-0.50

Income Statement

In the last 12 months, Pharma Mar SA had revenue of 174.85M and earned 26.13M in profits. Earnings per share was 1.48.
Revenue174.85M
Gross Profit166.67M
Operating Income6.47M
Pretax Income11.98M
Net Income26.13M
EBITDA21.23M
Earnings Per Share (EPS)1.48

Cash Flow

In the last 12 months, operating cash flow was -9.56M and capital expenditures -8.73M, giving a free cash flow of -18.29M billion.
Operating Cash Flow-9.56M
Free Cash Flow-18.29M
Free Cash Flow per Share-1.00

Dividends & Yields

Pharma Mar SA pays an annual dividend of $0.913, resulting in a dividend yield of 0.67%
Dividend Per Share$0.913
Dividend Yield0.67%
Payout Ratio48.48%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.05
52-Week Price Change155.73%
50-Day Moving Average90.19
200-Day Moving Average81.13
Relative Strength Index (RSI)61.60
Average Volume (3m)51.00

Important Dates

Pharma Mar SA upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 24, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJun 25, 2025

Financial Position

Pharma Mar SA as a current ratio of 3.03, with Debt / Equity ratio of 19.12%
Current Ratio3.03
Quick Ratio2.41
Debt to Market Cap0.03
Net Debt to EBITDA-0.57
Interest Coverage Ratio2.62

Taxes

In the past 12 months, Pharma Mar SA has paid -14.14M in taxes.
Income Tax-14.14M
Effective Tax Rate-1.18

Enterprise Valuation

Pharma Mar SA EV to EBITDA ratio is 65.37, with an EV/FCF ratio of -146.31.
EV to Sales7.93
EV to EBITDA65.37
EV to Free Cash Flow-146.31
EV to Operating Cash Flow230.21

Balance Sheet

Pharma Mar SA has $140.85M in cash and marketable securities with €51.94M in debt, giving a net cash position of -$88.91M billion.
Cash & Marketable Securities$140.85M
Total Debt€51.94M
Net Cash-$88.91M
Net Cash Per Share-$4.88
Tangible Book Value Per Share$11.82

Margins

Gross margin is 93.05%, with operating margin of 3.70%, and net profit margin of 14.94%.
Gross Margin93.05%
Operating Margin3.70%
Pretax Margin6.85%
Net Profit Margin14.94%
EBITDA Margin12.14%
EBIT Margin8.27%

Analyst Forecast

The average price target for Pharma Mar SA is $124.35, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$124.35
Price Target Upside19.01% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score10
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis